Furthermore, the treatment of psoriasis with TNF-α inhibitors may also have beneficial effects on the development of atherosclerosis and components of the metabolic syndrome, such as improving endothelial function, reducing the risk of diabetes mellitus, and improving insulin sensitivity (132). The gene discussed is INS; the disease is metabolic syndrome.